NCT05412693

Brief Summary

Stability dictates treatment choice for trans-syndesmotic fibula fractures. Optimal treatment for partially unstable fractures remains a topic of debate. The purpose of this study is to evaluate possible outcome non-inferior of functional orthosis treatment versus cast immobilization for these fractures.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

May 15, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

3.6 years

First QC Date

May 6, 2022

Last Update Submit

July 30, 2025

Conditions

Keywords

Weber BSER4a

Outcome Measures

Primary Outcomes (1)

  • Between-groups difference in Manchester-Oxford Foot and Ankle Questionnaire score at 2 years

    Scale 0-100, lower scores indicate less pain and symptoms.

    2 years

Secondary Outcomes (5)

  • Between-groups difference in Olerud Molander Ankle Score at 2 years

    2 years

  • Numeric rating scale of of patient satisfaction with treatment protocol

    6 weeks

  • Tibiotalar congruity comparing injured and uninjured ankle at 2 years

    2 years

  • Registrations of complications/adverse events

    2 years

  • Change from 6 weeks ankle range of motion at 2 years

    6 weeks, 2 years

Study Arms (2)

Functional orthosis

EXPERIMENTAL

Use of a functional orthosis device (AirCast Air-Stirrup) for 6 weeks. Weightbearing as tolerated will be allowed in both groups immediately after application of the cast or orthosis.

Device: Functional orthosis

Cast immobilization

ACTIVE COMPARATOR

Use of a below-the-knee cast circular cast (3M scotch cast) for 6 weeks.

Device: Cast immobilization

Interventions

See arm descriptions

Functional orthosis

See arm descriptions

Cast immobilization

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients:
  • With isolated Weber type B fractures that are deemed stable on weightbearing radiographs (MCS injured ankle - MCS uninjured ankle \< 1 mm).
  • With concomitant gravity stress test evaluated as unstable (MCS injured ankle - MCS uninjured ankle \< 1 mm)
  • Presenting to one of the participating hospitals, and that are available for stability evaluation within 14 days after injury.
  • years of age
  • With pre-injury walking ability without aids.

You may not qualify if:

  • Patients:
  • with fracture of the medial malleolus, pre-hospital closed fracture reduction, open fracture, fracture resulting from high-energy trauma or multi-trauma or pathologic fracture.
  • with fracture of the posterior malleolus involving 25% or more of the joint surface or with a step of the intraarticular surface. (non-displaced fractures smaller than 25% can be included)
  • with neuropathies and generalized joint disease such as Rheumatoid Arthritis.
  • that are assumed not compliant (drug use, cognitive- and/or psychiatric disorders).
  • with previous history of ipsilateral ankle fracture.
  • with previous history of ipsilateral major ankle-/foot surgery.
  • who live outside one of the participating hospitals catchment areas (not available for follow-up).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Ålesund Hospital

Ålesund, Norway

Location

Sykehuset Innlandet, Gjøvik

Gjøvik, Norway

Location

Østfold Hospital Trust

Sarpsborg, Østfold fylke, 1714, Norway

Location

MeSH Terms

Conditions

Ankle Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesAnkle InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Masking is not possible during the first 6 weeks of treatment due to the nature of the interventions. Investigators and outcome assessors will be masked for follow-up after 6 weeks.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Foot and Ankle Service

Study Record Dates

First Submitted

May 6, 2022

First Posted

June 9, 2022

Study Start

May 15, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations